Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Irish Stock Exchange  >  Malin Corporation plc    MLCM   IE00BVGC3741

MALIN CORPORATION PLC (MLCM)
Mes dernières consult.
Most popular
Report
 SummaryChartsNewsCalendarCompany 
Quotes 5-day view   End-of-day quote. End-of-day quote Irish Stock Exchange
12/05/2017 12/06/2017 12/07/2017 12/08/2017 12/11/2017 Date
9.75 9.75 9.75 9.75 9.75 Last
20 0 0 0 0 Volume
+2.63% 0.00% 0.00% 0.00% 0.00% Change
Company
Malin Corp. Plc. is a life sciences company.It acquires majority or significant minority equity positions in private, pre-Initial Public Offering, and pre-trade operating businesses in the life sciences industry particularly therapeutics, devices, and diagnostic companies.The company was founded on... 
Sector
Pharmaceuticals
Calendar
-
More about the company
Latest news on MALIN CORPORATION PLC
10/19 MALIN : appoints Dr. Andrew von Eschenbach, former FDA commissioner, as Chief Me..
10/10 MALIN : appoints Dr. Andrew von Eschenbach, former FDA commissioner, as Chief Me..
10/10 MALIN CORPORATION PLC : appoints Dr. Andrew von Eschenbach, former FDA commissio..
08/31 MALIN : Announces U.S. FDA Approval for New Hourglass™ Peripheral Embolisa..
08/22 MALIN : Announces U.S. FDA Approval for New Hourglass™ Peripheral Embolisa..
04/20 MALIN : Novan Reports Positive Topline Results with SB208 in Phase 2 Trial
02/15 MALIN : Investment in Wren Therapeutics
02/15 MALIN : Investment in Artizan Biosciences
02/06 MALIN : Makes Significant Commitment to Artizan Biosciences, Inc.
01/17 MALIN : Irish biotech investment firm Malin buys stake in U.K.'s Wren Therapeuti..
More news
Sector news : Pharmaceuticals - NEC
12:46p Sanofi investors hungry for drug progress and deal news
11:03aDJMERCK : Appoints Allan Gabor as Managing Director in China
08:42aDJGLAXOSMITHKLINE : Encouraged By Blood-Cancer Drug Study
07:32aDJSANOFI : Receives U.S. FDA Approval for Insulin Injection Admelog
12:56a Monsanto offers cash to U.S. farmers who use controversial chemical
More sector news : Pharmaceuticals - NEC
Chart MALIN CORPORATION PLC
Duration : Period :
Malin Corporation plc Technical Analysis Chart | MLCM | IE00BVGC3741 | 4-Traders
Technical analysis trends MALIN CORPORATION PLC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Average target price -
Spread / Average Target -100%
Managers
NameTitle
Adrian G. Howd Chief Executive Officer & Executive Director
Kyran McLaughlin Chairman
Neil McLoughlin Chief Operating Officer
Darragh Lyons Chief Financial Officer & Executive Director
Robert Alexander Ingram Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
MALIN CORPORATION PLC-20.08%486
JOHNSON & JOHNSON21.53%379 175
NOVARTIS12.15%218 773
PFIZER9.30%215 837
ROCHE HOLDING LTD.3.40%209 423
MERCK AND COMPANY-6.96%153 659